UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES AND EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): September 24, 2006
SPECTRUM PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
| Delaware
|
|
000-28782
|
|
93-0979187 |
| (State or other Jurisdiction
|
|
(Commission File Number)
|
|
(IRS Employer |
| of Incorporation)
|
|
|
|
Identification Number) |
| |
|
|
|
|
| 157 Technology Drive
|
|
|
|
92618 |
| Irvine, California
|
|
|
|
(Zip Code) |
| (Address of principal executive offices) |
|
|
|
|
(949) 788-6700
(Registrant’s telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
TABLE OF CONTENTS
Item 8.01 Other Events.
On
September 24, 2006, we issued a press release, discussing the results from our Phase 3
clinical trial for satraplatin. A copy of the press release is attached hereto as Exhibit 99.1 and
is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(c) Exhibits
| |
|
|
| Exhibits: |
|
Description of Document |
99.1
|
|
Press Release dated
September 24, 2006. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
|
|
|
|
|
|
Date: September 24, 2006 |
|
|
|
|
|
|
| |
|
SPECTRUM PHARMACEUTICALS, INC. |
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Shyam Kumaria |
|
|
|
|
|
|
|
|
|
|
|
Name:
|
|
Shyam Kumaria |
|
|
|
|
Title:
|
|
V.P. Finance |
|
|
-2-